Enovix Co. (NASDAQ:ENVX – Get Free Report) was up 5.8% during trading on Thursday . The company traded as high as $11.42 and last traded at $11.40. Approximately 2,675,972 shares were traded during mid-day trading, a decline of 70% from the average daily volume of 8,937,021 shares. The stock had previously closed at $10.78.
Analysts Set New Price Targets
Several equities analysts have recently weighed in on the stock. Benchmark reissued a “buy” rating and issued a $25.00 price target on shares of Enovix in a research note on Wednesday, October 30th. JPMorgan Chase & Co. dropped their target price on Enovix from $18.00 to $15.00 and set an “overweight” rating for the company in a report on Tuesday, October 22nd. Janney Montgomery Scott cut shares of Enovix from a “buy” rating to a “neutral” rating and set a $10.00 price objective for the company. in a research report on Thursday, October 31st. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $30.00 price target on shares of Enovix in a research note on Wednesday, October 30th. Two equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Enovix currently has a consensus rating of “Moderate Buy” and an average price target of $20.50.
Check Out Our Latest Stock Analysis on ENVX
Enovix Price Performance
Enovix (NASDAQ:ENVX – Get Free Report) last posted its quarterly earnings data on Tuesday, October 29th. The company reported ($0.17) EPS for the quarter, beating the consensus estimate of ($0.20) by $0.03. Enovix had a negative net margin of 1,180.21% and a negative return on equity of 102.19%. The business had revenue of $4.30 million during the quarter, compared to analyst estimates of $4.11 million. During the same quarter last year, the firm posted ($0.27) earnings per share. On average, equities analysts predict that Enovix Co. will post -1.17 earnings per share for the current year.
Insiders Place Their Bets
In other news, Director Betsy S. Atkins sold 75,000 shares of the stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $9.73, for a total value of $729,750.00. Following the completion of the sale, the director now directly owns 99,497 shares of the company’s stock, valued at approximately $968,105.81. This represents a 42.98 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 15.70% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Enovix
A number of institutional investors have recently modified their holdings of the business. Strong Tower Advisory Services increased its stake in Enovix by 167.5% in the fourth quarter. Strong Tower Advisory Services now owns 74,610 shares of the company’s stock valued at $811,000 after purchasing an additional 46,722 shares during the period. Udine Wealth Management Inc. raised its stake in Enovix by 1.7% during the 4th quarter. Udine Wealth Management Inc. now owns 207,040 shares of the company’s stock valued at $2,251,000 after acquiring an additional 3,556 shares during the last quarter. HB Wealth Management LLC lifted its position in Enovix by 63.0% during the 4th quarter. HB Wealth Management LLC now owns 16,628 shares of the company’s stock worth $181,000 after acquiring an additional 6,426 shares during the period. Wealthcare Advisory Partners LLC grew its stake in shares of Enovix by 6.2% in the 4th quarter. Wealthcare Advisory Partners LLC now owns 20,952 shares of the company’s stock valued at $228,000 after purchasing an additional 1,214 shares during the last quarter. Finally, Channel Wealth LLC increased its holdings in shares of Enovix by 12.9% in the fourth quarter. Channel Wealth LLC now owns 156,435 shares of the company’s stock valued at $1,700,000 after purchasing an additional 17,825 shares during the period. 50.92% of the stock is owned by institutional investors and hedge funds.
About Enovix
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Further Reading
- Five stocks we like better than Enovix
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- The 3 Best Blue-Chip Stocks to Buy Now
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.